The regulator cited "key concerns" including the trust's failure to deliver on its savings plans and the failure to successfully implement a new electronic patient records system.
However, statements from two commissioners also suggest that the CFTC, which is the regulator for the U.S. derivatives market, may be planning to look at the key benchmarks for a range of markets and not necessarily just singling out gold and silver.